Deguelin-Induced Inhibition of Cyclooxygenase-2 Expression in Human Bronchial Epithelial Cells

The increased expression of cyclooxygenase (COX)-2 significantly enhances carcinogenesis and inflammatory reactions, and its regulation may be a reasonable target for cancer chemoprevention. We demonstrated previously that deguelin inhibits proliferation of premalignant human bronchial epithelial (HBE) cells, such as 1799 cells and squamous HBE cells, by regulating phosphatidylinositol-3-kinase Akt activity, which is involved in COX-2 expression. We sought to determine the effect of deguelin on COX-2 expression in squamous HBE cells. Deguelin strongly inhibited COX-2 expression in squamous HBE cells, without affecting the COX-1 protein level. Deguelin inhibited proliferation of a variety of non-small cell lung carcinoma (NSCLC) cell lines through apoptosis and induced Bax expression in the H322 NSCLC and squamous HBE cells. Deguelin treatment did not affect Bcl-2 protein levels but increased expression levels of the proapoptotic protein p53 and the cyclin-dependent kinase inhibitors p21 and p27 in the squamous HBE cells. The sensitivity of the squamous HBE and NSCLC cells to deguelin and the inhibitory effects of deguelin on COX-2 expression in the squamous HBE cells indicate that regulation of COX-2 expression is involved in the chemopreventive action of deguelin in lung cancer.

[1]  J. Pezzuto,et al.  Regulation of ornithine decarboxylase induction by deguelin, a natural product cancer chemopreventive agent. , 1997, Cancer research.

[2]  Y. Yatabe,et al.  Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas. , 1998, Cancer research.

[3]  J. Pezzuto,et al.  Cancer chemopreventive activity mediated by deguelin, a naturally occurring rotenoid. , 1997, Cancer research.

[4]  J. Morrow,et al.  Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells. , 1998, Cancer research.

[5]  Pinchas Cohen,et al.  Insulin-like growth factor binding protein-3 inhibits the growth of non-small cell lung cancer. , 2002, Cancer research.

[6]  Bruno C. Hancock,et al.  Suppression of Intestinal Polyposis in Apc Δ716 Knockout Mice by Inhibition of Cyclooxygenase 2 (COX-2) , 1996, Cell.

[7]  K. Namboodiri,et al.  Nonsteroidal antiinflammatory drugs and breast cancer. , 1996, Epidemiology.

[8]  J. Morrow,et al.  A selective cyclooxygenase 2 inhibitor suppresses the growth of H-ras-transformed rat intestinal epithelial cells. , 1997, Gastroenterology.

[9]  R. Coffey,et al.  Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. , 1994, Gastroenterology.

[10]  J. Pezzuto,et al.  Pharmacokinetics of deguelin, a cancer chemopreventive agent in rats , 2001, Cancer Chemotherapy and Pharmacology.

[11]  R. White,et al.  Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: evidence for a transcriptional effect. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[12]  P. Lipsky,et al.  Cyclooxygenase in biology and disease , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[13]  M. Taketo,et al.  COX-2 and colon cancer , 1998, Inflammation Research.

[14]  M. Oren,et al.  p53; from inductive signal to cellular effect. , 1997, Current opinion in genetics & development.

[15]  E. Wynder,et al.  Increased expression of cyclooxygenase-2 in rat lung tumors induced by the tobacco-specific nitrosamine 4-(methylnitrosamino)-4-(3-pyridyl)-1-butanone: the impact of a high-fat diet. , 1999, Cancer research.

[16]  Y. Takei,et al.  Cyclooxygenase-2 inhibitors suppress the growth of gastric cancer xenografts via induction of apoptosis in nude mice. , 1998, The American journal of physiology.

[17]  M. Thun,et al.  Aspirin use and risk of fatal cancer. , 1993, Cancer research.

[18]  M. Sporn,et al.  Recent advances in chemoprevention of cancer. , 1997, Science.

[19]  P. Alexander.  Prostaglandins and cancer , 1982, Nature.

[20]  R. Lotan,et al.  Effects of deguelin on the phosphatidylinositol 3-kinase/Akt pathway and apoptosis in premalignant human bronchial epithelial cells. , 2003, Journal of the National Cancer Institute.

[21]  J. Trent,et al.  WAF1, a potential mediator of p53 tumor suppression , 1993, Cell.

[22]  C. Rao,et al.  Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound. , 1995, Cancer research.

[23]  N. Yoshimi,et al.  Apoptosis Induced by NS‐398, a Selective Cyclooxygenase‐2 Inhibitor, in Human Colorectal Cancer Cell Lines , 1997, Japanese journal of cancer research : Gann.

[24]  J. Casida,et al.  Anticancer action of cubé insecticide: correlation for rotenoid constituents between inhibition of NADH:ubiquinone oxidoreductase and induced ornithine decarboxylase activities. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[25]  H. Sheng,et al.  K-Ras-mediated increase in cyclooxygenase 2 mRNA stability involves activation of the protein kinase B1. , 2001, Cancer research.

[26]  Li Zhu,et al.  Non-small cell lung cancer cyclooxygenase-2-dependent regulation of cytokine balance in lymphocytes and macrophages: up-regulation of interleukin 10 and down-regulation of interleukin 12 production. , 1998, Cancer research.

[27]  P. Anzeveno.  Rotenoid interconversion. Synthesis of deguelin from rotenone , 1979 .

[28]  T. Fahey,et al.  Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer. , 1999, Cancer research.

[29]  A. Levine,et al.  NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells. , 1998, Cancer research.

[30]  R. Lotan,et al.  Retinoic acid receptor- and retinoid X receptor-selective retinoids activate signaling pathways that converge on AP-1 and inhibit squamous differentiation in human bronchial epithelial cells. , 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[31]  A. Ristimäki,et al.  Expression of cyclooxygenase-2 in human lung carcinoma. , 1998, Cancer research.

[32]  K. Seibert,et al.  Advances in Brief Evaluation of Cyclooxygenase-2 Inhibitor for Potential Chemopreventive Properties in Colon Carcinogenesis ' , 2006 .

[33]  M. Pollak,et al.  Insulin-like growth factor-I antagonizes the antiproliferative effects of cyclooxygenase-2 inhibitors on BxPC-3 pancreatic cancer cells. , 2002, Cancer research.

[34]  John Calvin Reed,et al.  Tumor suppressor p53 is a direct transcriptional activator of the human bax gene , 1995, Cell.

[35]  K. Subbaramaiah,et al.  Transcription of cyclooxygenase-2 is enhanced in transformed mammary epithelial cells. , 1996, Cancer research.

[36]  J. Mazuski,et al.  The effect of selective cyclooxygenase inhibitors on intestinal epithelial cell mitogenesis. , 1999, The Journal of surgical research.

[37]  F. Khuri,et al.  Emerging therapies in non-small-cell lung cancer. , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

[38]  R. Everson,et al.  Aspirin Use and Lung, Colon, and Breast Cancer Incidence in a Prospective Study , 1994, Epidemiology.